Concepedia

L. Pronk

LP

11

Publications

622

Citations

10

H-Index

1994

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Roche (Switzerland)

L. Pronk is an author at Rotterdam University of Applied Sciences specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1994–2007

11

Publications

11

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

Martin J. van den Bent, J. Kros, J.J. Heimans et al. · Neurology · 1998 · 202 citations

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

L. Pronk, P. Vasey, Alex Sparreboom et al. · British Journal of Cancer · 2000 · 96 citations · Full text

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

PHE Hilkens, L. Pronk, Jaap Verweij et al. · British Journal of Cancer · 1997 · 73 citations · Full text

, , +7

A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours

Gerhardt Attard, Jos Kitzen, Sarah P. Blagden et al. · British Journal of Cancer · 2007 · 71 citations · Full text

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.

L. Pronk, Jan H.M. Schellens, A.S.T. Planting et al. · Journal of Clinical Oncology · 1997 · 66 citations

Rows per page

1–5 of 11